No Photo Available

Last Update

2017-01-19T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Thomas Hecht?

Dr. Thomas Hecht

HQ Phone:

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Humabs BioMed AG

Humabs BioMed SA

Switzerland

Company Description

Humabs BioMed's (www.humabs.com) proprietary platforms are delivering a rich pipeline of high quality and distinct human monoclonal antibodies, particularly tailored to specific diseases. Humabs is working on a large portfolio and already has a diverse pi ... more

Find other employees at this company (11)

Background Information

Employment History

Chairman

VAXIMM AG

Founder and Owner

Hecht Healthcare Consulting

Vice President of Marketing

Amgen Inc.

Co-Head of the Program for Bone Marrow Transplantation

University of Freiburg

Chairman

Cell Medica Limited

Chairman

Affimed N.V.

Executive Chairman

Delenex Therapeutics AG

Chairman

ESBATech AG

Affiliations

Board Member
Clovis Oncology, Inc.

Chairman of the Investors Advisory Board
German Kidney Foundation Support Society

Chairman of the Investors Advisory Board
Heidelberg Innovation

Board Member
Cytos Biotechnology AG

Board Member
Kuros Biosciences Ltd

Chairman of the Supervisory Board
R&D Directions

Education

MD

degree

Economics

Web References (84 Total References)


Thomas Hecht, ...

www.vaximm.com [cached]

Thomas Hecht, MD Chairman Thomas Hecht, MD, Chairman is a seasoned manager and has extensive experience in the biopharmaceutical industry. Dr. Hecht is founder and owner of Hecht Healthcare Consulting, which provides marketing, clinical development and mergers & acquisitions services to the pharmaceutical/biotechnology industry. Previously, he was VP Marketing (Hematology, Oncology, New Products) at Amgen Europe. Before that, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen Europe. He currently serves as Chairman of the Boards of Affimed N.V. and Cell Medica Ltd., and as Member of the Board of Humabs BioMed AG. He was previously Chairman of the Boards of ESBATech AG (acquired by Alcon/Novartis in 2009), SuppreMol GmbH (acquired by Baxalta in 2015), and Cytos AG. Prior to joining the biopharmaceutical industry, Dr. Hecht was certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation, University of Freiburg, Germany.


Affimed

www.affimed.com [cached]

Dr. Thomas Hecht, Chairman

Dr. Hecht has been the Chairman of Affimed's Supervisory Board since 2007. He is Head of Hecht Healthcare Consulting in Küssnacht, Switzerland, a biopharmaceutical consulting company founded in 2002. Dr. Hecht also serves as Chairman of the Board of Directors of Cell Medica Ltd., Delenex AG, Vaximm AG and as a Director of Humabs BioMed AG. Until the beginning of March 2015, he served as Chairman of the Supervisory Council of SuppreMol GmbH. Dr. Hecht was previously Vice President Marketing at Amgen Europe. A seasoned manager and industry professional, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002. Prior to joining the biopharmaceutical industry, he was certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation at the University of Freiburg, Germany.


Thomas Hecht, ...

phx.corporate-ir.net [cached]

Thomas Hecht, Chairman. Dr. Hecht has been the chairman of our supervisory board since 2007. He is head of Hecht Healthcare Consulting in Küssnacht, Switzerland, a biopharmaceutical consulting company founded in 2002. Dr. Hecht also serves as chairman of the board of directors of Cell Medica Ltd., Delenex AG and as a director of Humabs BioMed AG. Until the beginning of March 2015, he served as chairman of the supervisory council of SuppreMol GmbH. Dr. Hecht was previously Vice President Marketing at Amgen Europe. A seasoned manager and industry professional, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002. Prior to joining the biopharmaceutical industry, he was certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation at the University of Freiburg, Germany.


Dr. Thomas Hecht and Dr. ...

www.vaximm.com [cached]

Dr. Thomas Hecht and Dr. Mathieu Simon join Board; Dr. Hecht appointed Chairman

...
Dr. Thomas Hecht and Dr. Mathieu Simon join Board; Dr. Hecht appointed Chairman
...
Basel (Switzerland) and Mannheim (Germany), June 23, 2016 - VAXIMM AG, a Swiss-German biotech company focused on developing oral T-cell immunotherapies, today announced the election of Thomas Hecht, MD, and Mathieu Simon, MD, as new members to its Board of Directors.
...
In addition, Dr. Hecht has been appointed as Chairman of the Board, taking over from Dr. Klaus Breiner, who will continue his role in the company as Vice-Chairman.
...
Thomas Hecht, MD is a seasoned manager and has extensive experience in the biopharmaceutical industry. Dr. Hecht is founder and owner of Hecht Healthcare Consulting, which provides marketing, clinical development and mergers & acquisitions services to the pharmaceutical/biotechnology industry. Previously, he was VP Marketing (Hematology, Oncology, New Products) at Amgen Europe. Before that, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen Europe. He currently serves as Executive Chairman of Delenex Therapeutics AG, as Chairman of the Boards of Affimed N.V. and Cell Medica Ltd., and as Member of the Board of Humabs BioMed AG. He was previously Chairman of the Boards of ESBATech AG (acquired by Alcon/Novartis in 2009), SuppreMol GmbH (acquired by Baxalta in 2015), and Cytos AG. Prior to joining the biopharmaceutical industry, Dr. Hecht was certified in internal medicine and served as Co- Head of the Program for Bone Marrow Transplantation, University of Freiburg, Germany.
...
Dr. Klaus Breiner, Vice-Chairman of VAXIMM, said: "Thomas and Mathieu have many years of highly relevant international experience in biotech and pharma, and we are all very pleased to have them join VAXIMM's Board.
...
Dr. Thomas Hecht said: "I am excited to have the opportunity to serve as Chairman of the Board of this emerging immune oncology company.


Dr. Thomas Hecht - Delenex Therapeutics

www.delenex.com [cached]

Dr. Thomas Hecht

Executive Chairman
MD, Chairman of the Board of Directors at Delenex since inception and Head of HHC consulting in Küssnacht, Switzerland. He was previously Vice President Marketing at Amgen Europe, Lucerne, Switzerland. A seasoned manager and industry professional, he has held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002. Prior to joining the biopharmaceutical industry, he certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation, University of Freiburg, Germany.
Today, he provides services to the pharmaceutical industry in clinical development/marketing and licensing strategies through HHC, a biopharmaceutical consulting company founded in 2002. He also serves as Chairman of the Boards of Affimed Therapeutics AG, Cell Medica Ltd., of the supervisory council of SuppreMol GmbH and as Member of the Board of Humabs BioMed AG. In 2009, with the acquisition by Alcon, he stepped down from the Chairmanship of ESBATech AG.

Similar Profiles

Other People with this Name

Other people with the name Hecht

Ronny Hecht
Urban Meridian Group Inc

Teri Hecht
Sinclair Community College

Davis Hecht
EyeMed Vision Care LLC

Alessyn Hecht
Barratt Galvin

Jonathan Hecht
vennarts-music.com

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory